Lyme-borreliosis - Update;Lyme-borreliose - Update

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 5, 2007, Pages 406-414

  Aberer, Elisabeth ^a  

^a Universitatsklinik fur Dermatologie und Venerologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BINDING PROTEIN; DECORIN; DECORIN BINDING PROTEIN A; OUTER SURFACE PROTEIN A; OUTER SURFACE PROTEIN B; PEPTIDE C10; PEPTIDE C6; PROTEIN BBK32; PROTEIN DBPA; PROTEIN VLSE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; B LYMPHOCYTE ACTIVATION; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; CELL MEDIATED LYMPHOLYSIS; CELLULAR IMMUNITY; COMPLEMENT DEPENDENT CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOST RANGE; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; LATENT PERIOD; LYME DISEASE; MACROPHAGE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PROTEIN BINDING; REINFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

BORRELIA BURGDORFERI GROUP; HUMANS; LYME DISEASE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SEROLOGIC TESTS;

EID: 34247482809     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06285.x     Document Type: Review

References (49)

1. Schaarschmidt D, Oehme R, Kimmig P, Hesch RD, Englisch S. Detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest Germany. Eur J Epidemiol 2001 17 (12 1067 1074.
2. Lünemann JD, Krause A. [Heterogeneity of Borrelia burgdorferi: etiopathogenetic relevance and clinical implications]. Z Rheumatol 2003 62 (2 148 154.
3. Hofmann H. [Lyme borreliosis Cutaneous manifestation.]. Hautarzt 2005 56 (8 783 796.
4. Stanek G, Strle F. Lyme borreliosis. Lancet 2003 362 (9396 1639 1647.
5. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis 2003 3 (8 489 500.
6. Masuzawa T. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia. Jpn J Infect Dis 2004 57 (6 229 235.
7. Kurtenbach K, De Michelis S, Etti S, Schafer SM, Sewell HS, Brade V, Kraiczy P. Host association of Borrelia burgdorferi sensu lato - the key role of host complement. Trends Microbiol 2002 10 (2 74 79.
8. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 1995 92 (7 2909 2913.
9. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997 390 (6660 580 586.
10. Al-Robaiy S, Knauer J, Straubinger RK. Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain. Infect Immun 2005 73 (9 5547 5553.
11. Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, Wormser GP, Schriefer ME, Luft BJ. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999 67 (7 3518 3524.
12. Dolan MC, Piesman J, Schneider BS, Schriefer M, Brandt K, Zeidner NS. Comparison of disseminated and nondisseminated strains of Borrelia burgdorferi sensu stricto in mice naturally infected by tick bite. Infect Immun 2004 72 (9 5262 5266.
13. Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM, Schwan TG, Policastro PF, Elias AF, Rosa PA. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 2004 101 (9 3142 3147.
14. Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, Byrne DW, Nowakowski J. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med 2005 142 (9 751 755.
15. Fuchs H, Simon MM, Wallich R, Bechtel M, Kramer MD. Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes. Infect Immun 1996 64 (10 4307 4312.
16. Coleman JL, Roemer EJ, Benach JL. Plasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix. Infect Immun 1999 67 (8 3929 3936.
17. Grab DJ, Kennedy R, Philipp MT. Borrelia burgdorferi possesses a collagenolytic activity. FEMS Microbiol Lett 1996 144 (1 39 45.
18. Kochi SK, Johnson RC, Dalmasso AP. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J Immunol 1991 146 (11 3964 3970.
19. Cordes FS, Roversi P, Kraiczy P, Simon MM, Brade V, Jahraus O, Wallis R, Skerka C, Zipfel PF, Wallich R, Lea SM. A novel fold for the factor H-binding protein BbCRASP-1 of Borrelia burgdorferi. Nat Struct Mol Biol 2005 12 (3 276 277.
20. Kraiczy P, Wurzner R. Complement escape of human pathogenic bacteria by acquisition of complement regulators Mol Immunol 2006 43 (1-2 31 44.
21. Pachner AR, Dail D, Bai Y, Sondey M, Pak L, Narayan K, Cadavid D. Genotype determines phenotype in experimental Lyme borreliosis. Ann Neurol 2004 56 (3 361 370.
22. Kuhlow CJ, Garcia-Monco JC, Coleman JL, Benach JL. Murine microglia are effective phagocytes for Borrelia burgdorferi. J Neuroimmunol 2005.
23. Georgilis K, Steere AC, Klempner MS. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis 1991 163 (1 150 155.
24. Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect 2004 10 (7 598 614.
25. Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK. Interaction between Borrelia burgdorferi and immature human dendritic cells. Scand J Immunol 2003 58 (1 67 75.
26. Cadavid D, Bai Y, Hodzic E, Narayan K, Barthold SW, Pachner AR. Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest 2004 84 (11 1439 1450.
27. Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 2004 165 (3 977 985.
28. Zhang JR, Norris SJ. Genetic variation of the Borrelia burgdorferi gene VlsE involves cassette-specific, segmental gene conversion. Infect Immun 1998 66 (8 3698 3704.
29. Liang FT, Jacobs MB, Bowers LC, Philipp MT. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 2002 195 (4 415 422.
30. Parveen N, Leong JM. Identification of a candidate glycosaminoglycan- binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000 35 (5 1220 1234.
31. Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, Cabello FC. Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect Immun 2004 72 (6 3138 3146.
32. Golde WT, Robinson-Dunn B, Stobierski MG, Dykhuizen D, Wang IN, Carlson V, Stiefel H, Shiflett S, Campbell GL. Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto. J Clin Microbiol 1998 36 (4 1015 1019.
33. Piesman J, Dolan MC, Happ CM, Luft BJ, Rooney SE, Mather TN, Golde WT. Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice. Infect Immun 1997 65 (10 4043 4047.
34. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005 18 (3 484 509.
35. Wilske B. Diagnosis of lyme borreliosis in Europe. Vector Borne Zoonotic Dis 2003 3 (4 215 227.
36. Schulte-Spechtel U, Lehnert G, Liegl G, Fingerle V, Heimerl C, Johnson BJ, Wilske B. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 2003 41 (3 1299 1303.
37. Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol 2005 43 (8 3602 3609.
38. Hauser U, Lehnert G, Wilske B. Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 1999 37 (7 2241 2247.
39. Panelius J, Lahdenne P, Heikkila T, Peltomaa M, Oksi J, Seppala I. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J Med Microbiol 2002 51 (9 731 739.
40. Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, Baxter-Lowe LA. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 2006 203 (4 961 971.
41. Heikkila T, Seppala I, Saxen H, Panelius J, Yrjanainen H, Lahdenne P. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J Clin Microbiol 2002 40 (2 453 460.
42. Heikkila T, Seppala I, Saxen H, Panelius J, Peltomaa M, Julin T, Carlsson ST, Lahdenne P. Recombinant BBK32 protein in serodiagnosis of early and late Lyme bor-reliosis. J Clin Microbiol 2002 40 (4 1174 1180.
43. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Jr., Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003 187 (8 1187 1199.
44. Hunfeld KP, Fingerle V, Stanek G, Daghofer E, Brade V, Wilske B, Peters H. European multicenter study for evaluation of a new enzyme immunoassay for detection of IgG antibodies against Borrelia burgdorferi sensu lato. 10th Int. conference on Lyme bor-reliosis and other tick-borne diseases, September 11-15, 2005, Vienna, Austria
45. Mathiesen MJ, Christiansen M, Hansen K, Holm A, Asbrink E, Theisen M. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol 1998 36 (12 3474 3479.
46. Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS. C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis. J Clin Microbiol 2003 41 (11 4955 4960.
47. Heikkila T, Huppertz HI, Seppala I, Sillanpaa H, Saxen H, Lahdenne P. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J Infect Dis 2003 187 (12 1888 1894.
48. Panelius J, Lahdenne P, Saxen H, Carlsson SA, Heikkila T, Peltomaa M, Lauhio A, Seppala I. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol 2003 250 (11 1318 1327.
49. Aberer E, Kersten A, Klade H, Poitschek C, Jurecka W. Heterogeneity of Borrelia burgdorferi in the skin. Am J Dermatopathol 1996 18 (6 571 579.